SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is experiencing intense volatility and social media attention as investors speculate on a major buyout and an imminent short squeeze following a significant increase in short interest and a high-stakes clinical trial readout. The community is sharply divided, with bulls pointing to institutional positioning and potential acquisition catalysts, while bears focus on trial outcome risks and concerns regarding share dilution.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors speculate on its potential inclusion in the Russell 1000 index, driving significant volume and heightened options activity. The community remains deeply divided between those betting on an imminent short squeeze and others warning that index-related optimism may be a temporary distraction from the company's long-term clinical and regulatory milestones.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is seeing intense debate as investors weigh concerns over SaaS valuations and AI disruption against its role as an enterprise orchestration layer, with community sentiment shifting between aggressive accumulation and frustration over recent volatility. Bullish traders are highlighting institutional insider buying and strategic partnerships as catalysts for a potential reversal, while bearish participants question the sustainability of the company's growth in an era of rapid AI development.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is seeing heightened volatility and debate as community members speculate on a potential price breakout, while others voice concerns regarding historical pump-and-dump patterns and lack of clear communication from the team. Traders are actively tracking technical indicators and volume spikes, with many discussing the risk-to-reward potential of holding the token amidst ongoing market fluctuations.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is currently trending as a primary play within the AI-infrastructure sector, with investors focused on the company's fuel cell technology as a solution to data center power and grid capacity bottlenecks. The community is actively debating the stock's valuation, recent price volatility linked to index rebalancing, and its long-term potential as a critical partner for major hyperscalers.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is generating intense community debate as investors weigh the company's defensive drone technology against ongoing concerns about management's communication and lack of significant contract revenue. While proponents emphasize the long-term potential of the firm's autonomous maritime and reconnaissance platforms in modern combat, skeptics are actively scrutinizing insider share sales and the impact of continuous dilution on shareholder value.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as shareholders express frustration over ongoing stock underperformance and the recent departure of its CFO, while active community debate focuses on the company's need for a potential acquisition of oncology-focused assets to revitalize its pipeline. Investors are closely monitoring the healthcare sector for signs of a rotation into value-oriented stocks, contrasting Pfizer's stagnant price action with the aggressive growth seen in peers like Eli Lilly.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is experiencing significant volatility driven by rapidly shifting geopolitical headlines between the U.S. and Iran, with community sentiment split between skepticism over potential "fake" peace deals and bullish anticipation for a holiday-week rally. Investors are actively debating the sustainability of the current market structure amid AI-sector rebalancing and recurring weekend war-related news cycles.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is currently experiencing significant market volatility driven by an 18% workforce reduction and the departure of its COO, as the company aggressively cuts costs to align with market demand. The community is polarized, with some investors highlighting the potential of the upcoming midsize platform and robotaxi partnerships as long-term catalysts, while many others are expressing deep frustration over persistent price declines, share dilution, and the ongoing struggle to achieve profitability.

ASP Isotopes, Inc. is developing a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy. It operates through the following segments: Nuclear Fuels, Specialist Isotopes and Related Services, and Helium and LNG. The Nuclear Fuels segment engages in the research and development of technologies and methods for producing HALEU and Lithium-6 for the advanced nuclear fuels target market, including the operations of QLE. The Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods for the separation of high-value, low-volume isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX.

ASP Isotopes Inc

ASP Isotopes is currently trending due to intense community focus on its pivot toward HALEU production and potential strategic partnerships within the nuclear and semiconductor sectors. While investors remain optimistic about the company's long-term helium assets and isotope enrichment capabilities, active discussions highlight tension regarding delayed milestones, recent stock volatility, and the impact of the company's complex corporate spin-out structure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Did SLS, MRNA, ABCL Stocks Surge To 52-Week Highs Last Week?

Equity

Investor interest has focused on companies nearing key milestones, signing major partnerships, or improving their business outlook. 


Stocks making the biggest moves midday: Moderna, ON Semiconductor, Rocket Lab, Eli Lilly, Sandisk & more

Here are the companies making headlines in midday trading...

Moderna (MRNA) Rises As Market Takes a Dip: Key Facts

Moderna (MRNA) closed at $61 in the latest trading session, marking a +2.79% move from the prior day.

Should You Buy Moderna Before Aug. 5?

Key PointsInvestors flocked to Moderna during early pandemic days as its coronavirus vaccine delivered blockbuster revenue...

Moderna Has Some Key Approvals Ahead. Is the Stock a Buy?

Key PointsModera grew revenue by 260% year over year in the first quarter...

MRNA Up as Influenza Vaccine Wins Unanimous FDA Advisory Panel Backing

Moderna stock gains 3.5% after FDA advisory panel votes 9-0 that mFlusiva's benefits outweigh risks in influenza prevention in older adults, ahead of an Aug. 5 decision.

MRNA Stock Clocks Best Week In Over 4 Years On FDA Advisory Committee Endorsement For Flu Vaccine

Jefferies noted that FDA decisions aligned with advisory committee recommendations 84% of the time between 2020 and 2025.


Bulls Pile Into Moderna As FDA Decision Nears, Ignites 60% Surge In This ETF

Moderna shares have surged nearly 30% in five days, ahead of a key FDA advisory vote on its flu vaccine, lifting the leveraged MRNX ETF more than 60%.read more...

MRNA Stock Jumps as FDA Briefing Docs Ease Flu Shot Approval Concerns

Moderna jumps after FDA briefing documents on mFlusiva appear more constructive than expected ahead of a key advisory panel review.

Moderna (MRNA) Surges 6.3%: Is This an Indication of Further Gains?

Moderna (MRNA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

Investors are hyper-focused on the company's shift toward oncology and T-cell therapies following positive data releases from Science Day.

Massive call buying activity and institutional accumulation are fueling volatile upward price momentum.

Anticipation builds around upcoming FDA decisions for flu vaccines and late-stage clinical readouts in the second half of the year.

Feed

News

Sentiment

Earnings

Fundamentals

Info

MRNAModerna Inc

Fundamentals

Latest MRNA News